Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction.
For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.
Female patients aged 25-50 years
Literate and able to comprehend written and spoken instructions
Diagnosed with relapsing-remitting form of multiple sclerosis
Having a continuous/regular sexual partner
Pregnancy
Illiteracy or inability to understand spoken or written instructions
Absence of a continuous/regular sexual partner
Expanded Disability Status Scale (EDSS) score > 5
Female patients with MS under follow-up at the Department of Neurology, Ege University.
Cohort
Cross-sectional
Not listed
Prevalence of sexual dysfunction in female patients with multiple sclerosis
Association between sexual dysfunction and cognitive dysfunction, fatigue, depression, anxiety, and overactive bladder symptoms
Click on the lead sponsor to view all of their trials.
